Real world assessment for Sofosbuvir + Velpatasvir therapy for decompensated cirrhotic patients with HCV
Not Applicable
Recruiting
- Conditions
- Decompensated cirrhotic patients with HCV
- Registration Number
- JPRN-UMIN000037258
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
Active Hepatocelluar Carcinoma Renal impairment; eGFR <30ml/min/1.73m2 Allergy to Sofosbuvir or Velpatasvir
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method